Skip to main content
Log in

Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses

  • Ultrasound
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objective

The American College of Radiology (ACR) recently published the ovarian-adnexal reporting and data system (O-RADS) to provide guidelines to physicians who interpret ultrasound (US) examinations of adnexal masses (AM). This study aimed to compare the O-RADS with two other well-established US classification systems for diagnosis of AM.

Methods

This retrospective multicenter study between May 2016 and December 2019 assessed consecutive women with AM detected by the US. Five experienced consultant radiologists independently categorized each AM according to O-RADS, gynecologic imaging reporting and data system (GI-RADS), and international ovarian tumor analysis (IOTA) simple rules. Pathology and adequate follow-up were used as reference standards for calculating the validity of three US classification systems for diagnosis of AM. Kappa statistics were used to assess the inter-reviewer agreement (IRA).

Results

A total of 609 women (mean age, 48 ± 13.7 years; range, 18–72 years) with 647 AM were included. Of the 647 AM, 178 were malignant and 469 were benign. Malignancy rates were comparable to recommended rates by previous literature in O-RADS and IOTA, but higher in GI-RADS. O-RADS had significantly higher sensitivity for malignancy than GI-RAD and IOTA (p = 0.003 and 0.0007, respectively), but non-significant slightly lower specificity (p > 0.05). O-RADS, GI-RADS, and IOTA showed similar overall IRA (κ = 0.77, 0.69, and 0.63, respectively) with a tendency toward higher IRA with O-RADS than with GI-RADS and IOTA.

Conclusions

O-RADS compares favorably with GI-RADS and IOTA. O-RADS had higher sensitivity than GI-RADS and IOTA simple rules with relatively similar specificity and reliability.

Key Points

• The malignancy rates were comparable to recommended rates by previous literature in O-RADS and IOTA, but higher in GI-RADS.

• The O-RADS had significantly higher sensitivity for malignancy than GI-RADS and IOTA (96.8% vs 92.7% and 92.1%; p = 0.003 and 0.0007, respectively), but non-significant slightly lower specificity (92.8% vs 93.6% and 93.2%, respectively; p > 0.05).

• The O-RADS, GI-RADS, and IOTA showed similar overall inter-reviewer agreement (IRA) (κ = 0.77, 0.69, and 0.63, respectively), with a tendency toward higher IRA with O-RADS than with GI-RADS and IOTA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

AM:

Adnexal masses

AUC:

Area under the curve

FIGO:

Federation of Gynaecology and Obstetrics

GI-RADS:

Gynecologic Imaging Reporting and Data System

IOTA:

International Ovarian Tumor Analysis

IRA:

Inter-reviewer agreement

O-RADS:

Ovarian-Adnexal Reporting and Data System

ROC:

Receiver operating characteristic

US:

Ultrasound

References

  1. American College of Radiology. ACR appropriateness criteria 2008: clinically suspected adnexal mass. American College of Radiology Web site. Available at http://www.acr.org/SecondaryMainMenuCategories/quality_safety/app_criteria/pdf/ExpertPanelonWomensImaging/SuspectedAdnexalMassesDoc11.aspx. Accessed 9 Nov 2009

  2. Liu J, Xu Y, Wang J (2007) Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis of ovarian carcinoma. Eur J Radiol 62:328–334

    Article  Google Scholar 

  3. Levine D, Brown DL, Andreotti RF et al (2010) Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 256:943–954

    Article  Google Scholar 

  4. Timmerman D, Valentin L, Bourne TH et al (2000) Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 16:500–505

    Article  CAS  Google Scholar 

  5. Timmerman D, Testa AC, Bourne T et al (2008) Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound Obstet Gynecol 31:681–690

    Article  CAS  Google Scholar 

  6. Timmerman D, Van Calster B, Testa A et al (2016) Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group. Am J Obstet Gynecol 214:424–437

    Article  Google Scholar 

  7. Van Calster B, Van Hoorde K, Valentin L et al (2014) Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ 349:g5920

    Article  Google Scholar 

  8. Van Calster B, Timmerman D, Valentin L et al (2012) Triaging women with ovarian masses for surgery: observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis (IOTA) group protocol. BJOG 119:662–671

    Article  Google Scholar 

  9. Amor F, Vaccaro H, Alcázar JL, León M, Craig JM, Martinez J (2009) Gynecologic imaging reporting and data system: a new proposal for classifying adnexal masses on the basis of sonographic findings. J Ultrasound Med 28:285–291

  10. Amor F, Alcázar JL, Vaccaro H, León M, Iturra A (2011) GI-RADS reporting system for ultrasound evaluation of adnexal masses in clinical practice: a prospective multicenter study. Ultrasound Obstet Gynecol 38:450–455

  11. Kaijser J, Sayasneh A, Van Hoorde K et al (2014) Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis. Hum Reprod Update 20:449–462

    Article  Google Scholar 

  12. Andreotti RF, Timmerman D, Benacerraf BR et al (2018) Ovarian-adnexal reporting lexicon for ultrasound: a white paper of the ACR Ovarian-Adnexal Reporting and Data System Committee. J Am Coll Radiol 15:1415–1429

    Article  Google Scholar 

  13. Andreotti RF, Timmerman D, Strachowski LM et al (2019) O-RADS US Risk Stratification and Management System: a consensus guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Radiology 294:168–185

  14. Basha MAA, Refaat R, Ibrahim SA et al (2019) Gynecology Imaging Reporting and Data System (GI-RADS): diagnostic performance and inter-reviewer agreement. Eur Radiol 29:5981–5990

    Article  Google Scholar 

  15. Heintz AP, Odicino F, Maisonneuve P et al (2003) Carcinoma of the ovary. Int J Gynecol Obstet 83:135–166

    Article  Google Scholar 

  16. Orozco Fernández R, Peces Rama A, Llanos Llanos MC, Martinez Mendoza A, Machado Linde F, Nieto Diaz A (2015) Clinical application of the gynecologic imaging reporting and data system (GI-RADS) for the evaluation of adnexal masses. SM J Gynecol Obstet 1:1009–1012

    Google Scholar 

  17. Zhang T, Li F, Liu J, Zhang S (2017) Diagnostic performance of the Gynecology Imaging Reporting and Data System for malignant adnexal masses. Int J Gynaecol Obstet 137:325–331

    Article  Google Scholar 

  18. Migda M, Bartosz M, Migda MS, Kierszk M, Katarzyna G, Maleńczyk M (2018) Diagnostic value of the gynecology imaging reporting and data system (GI-RADS) with the ovarian malignancy marker CA-125 in preoperative adnexal tumor assessment. J Ovarian Res 11:92

    Article  Google Scholar 

  19. Rams N, Muñoz R, Soler C, Parra J (2015) Resultados de la clasificación Gynecologic Imaging Reporting and Data System para la catalogación de masas anexiales. Prog Obstet Ginecol 58:125–129

  20. Alcazar JL, Pascual MA, Graupera B et al (2016) External validation of IOTA simple descriptors and simple rules for classifying adnexal masses. Ultrasound Obstet Gynecol 48:397–402

    Article  CAS  Google Scholar 

  21. Koneczny J, Czekierdowski A, Florczak M, Poziemski P, Stachowicz N, Borowski D (2017) The use of sonographic subjective tumor assessment, IOTA logistic regression model 1, IOTA Simple Rules and GI-RADS system in the preoperative prediction of malignancy in women with adnexal masses. Ginekol Pol 88:647–653

    Article  Google Scholar 

  22. Timmerman D, Ameye L, Fischerova D et al (2010) Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ 341:c6839

    Article  Google Scholar 

  23. Garg S, Kaur A, Mohi JK, Sibia PK, Kaur N (2017) Evaluation of IOTA simple ultrasound rules to distinguish benign and malignant ovarian tumours. J Clin Diagn Res 11:TC06

    PubMed  PubMed Central  Google Scholar 

  24. Wynants L, Timmerman D, Verbakel JY et al (2017) Clinical utility of risk models to refer patients with adnexal masses to specialized oncology care: multicenter external validation using decision curve analysis. Clin Cancer Res 23:5082–5090

    Article  Google Scholar 

  25. Timmerman D, Testa AC, Bourne T et al (2005) Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol 23:8794–8801

    Article  Google Scholar 

  26. Zannoni L, Savelli L, Jokubkiene L et al (2006) Intra-and inter-observer agreement with regard to describing adnexal masses using International Ovarian Tumor Analysis (IOTA) terminology: a reproducibility study involving seven observers. Ultrasound Obstet Gynecol 44:100 –108

  27. Ruiz de Gauna B, Sanchez P, Pineda L, Utrilla-Layna J, Juez L, Alcazar JL (2014) Interobserver agreement in describing adnexal masses using the International Ovarian Tumor Analysis simple rules in a real-time setting and using three-dimensional ultrasound volumes and digital clips. Ultrasound Obstet Gynecol 44:95–99

Download references

Acknowledgments

The authors thank all staff members and colleagues in the Radiology and Obstetrics& Gynecology Departments at Zagazig and Benha Universities, and Al-Ahrar Teaching Hospital for their helpful cooperation.

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohammad Abd Alkhalik Basha.

Ethics declarations

Guarantor

The scientific guarantor of this publication is the corresponding author: Mohammad Abd Alkhalik Basha.

Conflict of interest

The author of this manuscript declare no relevant conflicts of interest, and no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

The corresponding author has great statistical expertise

Informed consent

Written informed consent was obtained from all patients.

Ethical approval

Institutional review boards’ approval was obtained.

Study subjects or cohorts overlap

A subset of the data, on 258 of the 609 women, was previously published [Basha, M.A.A., Refaat, R., Ibrahim, S.A. et al. Eur Radiol (2019) 29: 5981. https://doi.org/10.1007/s00330-019-06181-0]. The prior study evaluated diagnostic performance and IRA of the GI-RADS for diagnosis of AM by US; in the current study, we compared the O-RADS with GI-RADS and IOTA regarding their validity and reliability for the US diagnosis of AM.

Methodology

• Retrospective

• Diagnostic or prognostic study

• Performed at multiple centres

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 18 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Basha, M.A., Metwally, M.I., Gamil, S.A. et al. Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses. Eur Radiol 31, 674–684 (2021). https://doi.org/10.1007/s00330-020-07143-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-020-07143-7

Keywords

Navigation